Related Experiment Videos
Protein binding characteristics of a new bronchodilator, 1-methyl-3-propylxanthine (MPX), in different species
R Apichartpichean1, K Takagi, T Kuzuya
1Department of Hospital Pharmacy, Nagoya University School of Medicine, Japan.
Abstract:
The protein binding of a new bronchodilator, 1-methyl-3-propylxanthine (MPX), in different animal species sera (human, dog, rabbit, rat and mouse) was investigated in vitro by ultrafiltration method. Interspecies differences in the binding affinity and binding capacity for MPX were observed. The dissociation constant (Kd1) for the high affinity binding site of human serum was approximately 17 times higher than that of rat serum. Those of rat serum and rabbit serum were nearly equal. On the other hand, the binding indices (n1p1/kd1) of human serum and rat serum were comparable. The binding of MPX to various proteins such as human serum albumin (HSA), alpha 1-acid glycoprotein (AGP) and isolated human lipoproteins was also investigated. The binding of MPX to HSA was lower than that of human serum protein but the number of specific binding sites (n1) in human serum was in agreement with that in HSA. The binding curves of MPX to AGP and lipoproteins were almost linear and the binding percentages were less than 7% in both cases. These data suggest that MPX is exclusively bound to albumin and that AGP and lipoproteins are of little importance in the protein binding of MPX. The present data appear to be useful for predicting the role of protein binding on the pharmacokinetics of MPX in different animal species.
Insights
Protein binding of the new bronchodilator 1-methyl-3-propylxanthine (MPX) varies significantly across animal species. MPX primarily binds to albumin, with implications for its pharmacokinetics in different species.
Area of Science:
- Pharmacology
- Biochemistry
- Drug Metabolism
Background:
- Protein binding is a critical factor influencing drug pharmacokinetics.
- Understanding interspecies differences in drug binding is essential for preclinical drug development.
Purpose of the Study:
- To investigate the in vitro protein binding of 1-methyl-3-propylxanthine (MPX) in various animal sera.
- To determine the binding affinity and capacity of MPX to different serum proteins.
Main Methods:
- In vitro ultrafiltration method was employed.
- Protein binding of MPX was assessed in human, dog, rabbit, rat, and mouse sera.
- Binding to human serum albumin (HSA), alpha 1-acid glycoprotein (AGP), and lipoproteins was evaluated.
Main Results:
- Significant interspecies differences in MPX binding affinity and capacity were observed.
- Human serum exhibited a 17-fold higher dissociation constant (Kd1) compared to rat serum.
- MPX primarily binds to albumin, with minimal binding to AGP and lipoproteins.
Conclusions:
- The protein binding of MPX differs considerably across species.
- Albumin is the predominant binding protein for MPX.
- These findings are crucial for predicting the pharmacokinetic behavior of MPX in different animal models.